October 20, 2020

CLL Society Webinar “The Future of CAR-T Therapy: Can CAR-T Cure CLL?”

Join us on November 17 with CAR-T researcher Dr. Joe Fraietta. While CAR-T therapy is not yet approved for use in CLL, there are CLL patients who have received CAR-T in clinical trials who remain cancer-free 10 years after therapy! So, show up for “class” on Nov. 17 as all of us strive to learn all we can about how this promising “living drug” works. Register today!

Conference Coverage ASH 2019 

ASH 2019 interview with Dr. Sameer Parikh: Did you know that there is a pre-cancerous condition known as Monoclonal B-cell lymphocytosis (MBL) which is present in 5% of the population over age 40? Most people with “low count” MBL will never develop CLL. Dr. Sameer Parikh is interested in studying what early changes differentiate MBL from other conditions and what causes a “high-count” MBL to progress to CLL. Learn more here.

CLL Society 2020 Patient Survey on MRD testing & Limited Duration Therapy:

When CLL Society takes on a learning initiative to give you in-depth mastery of any important subject, our lessons are never “one and done”! We stay with you until learning is complete. How do we do it? We survey the collective knowledge of our readers to determine what you still “yearn to learn” so that we can best tailor future learning for you. Our MRD & LD Survey is still in play. Please help us out by giving your thoughts. Thanks!

Practicing with the Patient Voice: A Patient Decision Library: Wow! There is only one thing more informative and helpful than hearing 4 CLL patients describe the treatment decisions they faced and that is the addition of 2 outstanding young CLL experts (Drs. Anthony Mato and Matthew Davids) in their on-camera discussion of the challenges each step of the way for these 4 patients. The CLL Society is pleased to have partnered with Platform Q on their Cancer Coach Live virtual case library – 4 patient stories. Check it out! 

CURE® Educated Patient® Leukemia & Lymphoma Summit 

Join us for the CURE® Educated Patient® Leukemia & Lymphoma Summit on Oct. 24 at 10am ET! Individuals of all cancer stages and their caregivers are cordially invited to join this informative full-day virtual event. Connect with the leukemia and lymphoma community online and learn more about cancer care from expert faculty. Learn more and register here.

Lymphoma Leukemia & Myeloma 2020 Virtual Congress 

Recognized as one of the most respected forums for industry-leading hematologic research and clinical case studies, the Lymphoma, Leukemia and Myeloma Congress is the meeting where interdisciplinary specialists convene to explore the controversial and complex world of blood cancer through debate, discussion and networking. The 20th anniversary of the meeting will be held virtually October 21- 24 and will feature a Non-Malignant Hematology Pre-Conference Workshop on October 20. Healthcare Providers can earn 30+ CME credits from the comfort of their home or office while participating in this virtual event. Learn more and register here. 

Regulatory News

The safety and efficacy of venetoclax in an older, frail population was confirmed in Friday’s FDA approval of venetoclax for use in AML (acute myeloid leukemia). Read why this is important to CLL patients and access the Press Release here.

Support the CLL Society!

The CLL Society is invested in your long life.

Please invest in the long life of the CLL Society by supporting our work.